Top News

How will OpenAI revolutionize healthcare? Sam Altman has an idea
25 Mar 2026

Sam Altman has announced a new initiative to revolutionize healthcare with artificial intelligence (AI).

The effort is part of the larger work of the OpenAI Foundation, which is now investing heavily in real-world applications of AI.

The main goal is to speed up medical research and improve patient care outcomes by using AI technologies.

Initiative focuses on life sciences and disease research
Initiative

The OpenAI Foundation's new initiative is focused on life sciences and disease research.

It aims to support researchers in using AI for better understanding of diseases, identifying treatment pathways, and speeding up therapy development.

The program also includes detecting clinical biomarkers for care and trials, and enabling personalized treatments.

Repurposing existing approved drugs to cut down therapy delivery time and costs is another key focus area of this initiative.

Expanding access to public health data
Technological advancement

The OpenAI Foundation believes that AI systems can analyze complex biological data, providing new ways to study diseases.

This could greatly speed up the transition from early-stage research to real-world treatment.

The initiative also aims at expanding access to high-quality public health data by creating and expanding datasets with partners, opening previously restricted data responsibly where possible.

Addressing high-burden diseases with AI
Disease focus

The OpenAI Foundation's initiative also targets high-mortality and high-burden diseases that get little funding.

The organization hopes AI can cut down the cost and risk of developing/repurposing therapies in these areas.

Over the next year, it plans to invest at least $1 billion across key areas like life sciences, jobs and economic impact, AI resilience, and community programs.